A carregar...
Ipilimumab in a Phase II trial of melanoma patients with brain metastases
In a Phase II clinical study enrolling individuals with melanoma brain metastases, 51 asymptomatic patients (cohort A) and 21 on a stable steroid dose (cohort B) received 4 courses of 10 mg/kg intravenous ipilimumab (induction), then (at 24 weeks) maintenance therapy with the same dose of ipilimumab...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Landes Bioscience
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3494644/ https://ncbi.nlm.nih.gov/pubmed/23170278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.20687 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|